Literature DB >> 8261612

Midkine that promotes survival of fetal human neurons is produced by fetal human astrocytes in culture.

J Satoh1, H Muramatsu, G Moretto, T Muramatsu, H J Chang, S T Kim, J M Cho, S U Kim.   

Abstract

Midkine (MK), a retinoic acid responsive gene product, is a novel heparin-binding growth factor with an apparent molecular weight of 14-kDa. In fetal human neuron cultures, addition of recombinant human MK (10-100 ng/ml) resulted in a 3-fold increase in the number of surviving neurons under the serum-free culture condition. Production of MK was identified in the conditioned medium of astrocyte-enriched cultures by immunoblotting but not in the medium of neuron-enriched cultures. The level of MK production was not affected by treatment with retinoic acid. These results indicate that in the developing human central nervous system, astrocytes secrete MK that exhibits potent trophic activity to neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261612     DOI: 10.1016/0165-3806(93)90024-5

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  15 in total

Review 1.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 2.  Midkine and cytoplasmic maturation of mammalian oocytes in the context of ovarian follicle physiology.

Authors:  Shuntaro Ikeda; Masayasu Yamada
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 3.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus.

Authors:  Yun B Kim; Jae K Ryu; Hong J Lee; In J Lim; Dongsun Park; Min C Lee; Seung U Kim
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

5.  Requirements for Neurogenin2 during mouse postnatal retinal neurogenesis.

Authors:  Angelica M Kowalchuk; Kate A Maurer; Farnaz Shoja-Taheri; Nadean L Brown
Journal:  Dev Biol       Date:  2018-07-24       Impact factor: 3.582

Review 6.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.

Authors:  Takashi Muramatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

7.  The effects of early exercise on brain damage and recovery after focal cerebral infarction in rats.

Authors:  F Matsuda; H Sakakima; Y Yoshida
Journal:  Acta Physiol (Oxf)       Date:  2011-02       Impact factor: 6.311

Review 8.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 9.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

Review 10.  Midkine in repair of the injured nervous system.

Authors:  Yoshihiro Yoshida; Harutoshi Sakakima; Fumiyo Matsuda; Masako Ikutomo
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.